Overview
- 23 inspections across 22 sites are on record.
- 60 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
23
Sites
22
Observations
60
Career since
Jan 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Northland Nuclear Medicine, LLC | 29 May 2026 | Human Drugs | View 483 → |
| Blessings International | 14 May 2026 | Human Drugs | View 483 → |
| MPP PHARMA LLC | 2 Apr 2026 | Human Drugs | View 483 → |
| Cardinal Health, MSU P.E.T. Site | 22 Jan 2026 | Human Drugs | View 483 → |
| ABS Corporation | 16 Jan 2026 | Animal Drugs & Feeds | View 483 → |
Sites inspected
Northland Nuclear Medicine, LLCBismarck, United States1 insp.
Blessings InternationalBroken Arrow, United States1 insp.
MPP PHARMA LLCKansas City, United States1 insp.
Cardinal Health, MSU P.E.T. SiteEast Lansing, United States1 insp.
ABS CorporationOmaha, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joohi Castelvetere2 shared
Jacob G Lutz2 shared
Robert J Ham2 shared
Vaishali J Patel1 shared
Shannon L Maisano1 shared
Elizabeth R Bloom1 shared
Tianhong Zhou1 shared
Michele L Obert1 shared
Ramia Brzenjy1 shared
Mary L Schuckmann1 shared
Full investigator report
Get the verbatim findings behind Melissa M Steiger's 60 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site